Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honglin Luo

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 20, 2004
A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse heartsJi Yuan, Paul K M Cheung, Huifang Zhang, et al.
Circulation Research|June 29, 2002
Nip21 gene expression reduces coxsackievirus B3 replication by promoting apoptotic cell death via a mitochondria-dependent pathwayHuifang M Zhang, Bobby Yanagawa, Paul Cheung, et al.
Molecular Therapy Oncolytics|February 12, 2021
Erratum: MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Molecular Therapy Oncolytics|March 4, 2020
MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Cell Host & Microbe|January 22, 2013
An ERK-p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infectionKarin J Jensen, Farshid S Garmaroudi, Jingchun Zhang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 21, 2003
Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in miceBobby Yanagawa, O Brad Spiller, Jonathan Choy, et al.
Molecular Therapy Oncolytics|August 30, 2019
Coxsackievirus Type B3 Is a Potent Oncolytic Virus against <i>KRAS</i>-Mutant Lung AdenocarcinomaHaoyu Deng, Huitao Liu, Tanya de Silva, et al.
Journal of Cellular and Molecular Medicine|March 19, 2024
Combining bulk and scRNA-seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDACShaoliang Zhu, Quan Cheng, Mengjie Zou, et al.
Circulation Research|February 14, 2009
Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during coxsackievirus-induced myocarditisDavid Marchant, Ying Dou, Honglin Luo, et al.
Circulation|March 12, 2008
Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in miceCaroline Cheung, David Marchant, Elizabeth K-Y Walker, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 20, 2004
A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse heartsJi Yuan, Paul K M Cheung, Huifang Zhang, et al.
Circulation Research|June 29, 2002
Nip21 gene expression reduces coxsackievirus B3 replication by promoting apoptotic cell death via a mitochondria-dependent pathwayHuifang M Zhang, Bobby Yanagawa, Paul Cheung, et al.
Molecular Therapy Oncolytics|February 12, 2021
Erratum: MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Molecular Therapy Oncolytics|March 4, 2020
MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung CancerHuitao Liu, Yuan Chao Xue, Haoyu Deng, et al.
Cell Host & Microbe|January 22, 2013
An ERK-p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infectionKarin J Jensen, Farshid S Garmaroudi, Jingchun Zhang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 21, 2003
Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in miceBobby Yanagawa, O Brad Spiller, Jonathan Choy, et al.
Molecular Therapy Oncolytics|August 30, 2019
Coxsackievirus Type B3 Is a Potent Oncolytic Virus against <i>KRAS</i>-Mutant Lung AdenocarcinomaHaoyu Deng, Huitao Liu, Tanya de Silva, et al.
Journal of Cellular and Molecular Medicine|March 19, 2024
Combining bulk and scRNA-seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDACShaoliang Zhu, Quan Cheng, Mengjie Zou, et al.
Circulation Research|February 14, 2009
Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during coxsackievirus-induced myocarditisDavid Marchant, Ying Dou, Honglin Luo, et al.
Circulation|March 12, 2008
Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in miceCaroline Cheung, David Marchant, Elizabeth K-Y Walker, et al.
Pageof 20